Anti-Angiogenic Agents in Pancreatic Cancer: A Review

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 5, 2011-01 ,pp. : 464-469

Bentham Science Publishers

Access to resources Recommend Favorite

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents

By Aragon-Ching Jeanny   Ning Yang-Min   Chen Clara   Latham Lea   Guadagnini Jean-Pierre   Gulley James   Arlen Philip   Wright John   Parnes Howard   Figg William   Dahut William  

Cancer Investigation, Vol. 27, Iss. 2, 2009-02 ,pp. : 221-226

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-Angiogenic Therapy as a Cancer Treatment Paradigm

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 5, Iss. 2, 2005-03 ,pp. : 115-130

Bentham Science Publishers

Access to resources Recommend Favorite

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 15, Iss. 1, 2015-01 ,pp. : 37-47

Bentham Science Publishers

Access to resources Recommend Favorite